Search results
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 5 days agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 5 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its ...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 4 days agoModerna Inc (NASDAQ:MRNA) reported a net loss of $1.2 billion for the period, compared to net income...understand, as you've communicated with large retail pharmacy, how significant ...
'Fighting for Approval': Barriers to Needed Medications
Medscape· 6 days agoTherapies such as growth hormones and puberty blockers often face shortages, leaving pediatric...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 5 days agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna Reports First Quarter 2024 Financial Results and Provides Business Updates
Digital Journal· 5 days agoReports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 ...
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050
KFDX Wichita Falls· 6 days ago(CSE: BIOV) (OTCQB: BVAXF), Moderna, Inc. (NASDAQ: MRNA), Boundless Bio, Inc. (NASDAQ: BOLD),...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 5 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 5 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Moderna Inc (MRNA, Financial) reported substantial clinical progress with ...
Biotech’s bind over China bill
Politico· 4 days agoMODERNA BULLISH ON RSV SHOT — Moderna executives signaled confidence Thursday that the drugmaker’s RSV vaccine can compete with shots already on the market ...